𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil

✍ Scribed by David Páez; Laia Paré; Albert Altés; Francesc Josep Sancho-Poch; Lourdes Petriz; Jordi Garriga; Josep Maria Monill; Juliana Salazar; Elisabeth del Rio; Agustí Barnadas; Eugenio Marcuello; Montserrat Baiget

Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
330 KB
Volume
136
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The prognostic significance of thymidyla
The prognostic significance of thymidylate synthase and dihydropyrimidine dehydrogenase in colorectal cancer of 303 patients adjuvantly treated with 5-fluorouracil
✍ Søren Astrup Jensen; Ben Vainer; Jens Benn Sørensen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 350 KB

## Abstract Cytotoxic effect of 5‐fluorouracil 5‐FU is mediated through inhibition of thymidylate synthase (TS), and 5‐FU is catabolised by dihydropyrimidine dehydrogenase (DPD). Efficacy of 5‐FU may therefore depend on the TS and DPD activity of colorectal cancer. Archival tumour specimens from 30

Single nucleotide polymorphism in the 5′
Single nucleotide polymorphism in the 5′ tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients
✍ Eugenio Marcuello; Albert Altés; Elisabeth del Rio; Angeles César; Anna Menoyo; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB 👁 1 views

## Abstract Thymidylate synthase (TS) is the primary target of 5‐fluorouracil (5‐FU). A VNTR polymorphism in the TS promoter region is associated with the efficacy of 5‐FU‐based chemotherapy in colorectal cancer. A common G>C SNP at the 12th nucleotide of the second repeat in the TS\*3 alleles has